Restoration of Listing

Summary by AI BETAClose X

Octagon Healthcare Funding plc announces that its £341,328,000 5.333 per cent. Guaranteed Secured Bonds due 2035 have been restored to the Main Market of the London Stock Exchange, effective from 7:30 am on 13 August 2026, following a temporary suspension. This restoration means the bonds are once again listed on the Official List, with the ISIN XS0181523803 and categorized under Standard Debt.

Disclaimer*

Octagon Healthcare Funding PLC
13 August 2026
 

Octagon Healthcare Funding plc

 

NOTIFICATION UPDATE ON RESTORATION OF LISTING FROM THE OFFICIAL LIST

 

Octagon Healthcare Funding plc ("Octagon" or the "Company") provides the following update in relation to the temporary suspension of the Company's £341,328,000 5.333 per cent. Guaranteed Secured Bonds due 2035 (the "Bonds") on the Main Market of the London Stock Exchange from 07:30 am on 1 May 2026 to 07.30 am on 13 August 2026. Effective from 7.30 am on 13 August 2026, Octagon confirms that The Financial Conduct Authority restored the Company's Bonds to the Main Market of the London Stock Exchange as set out below.

 

Security Description     

Listing Category           

 

ISIN

5.333% Guaranteed Secured Bonds due 31/12/2035; fully paid; (Represented by bonds to bearer of GBP1,000, GBP10,000
 & GBP100,000 each) (Regulation S)

Standard Debt

XS0181523803

 

The RNS confirming the restoration of listing to the official list being effective from 7.30 am on 13 August 2026 was released within the Official List Notice.

 

This notification update has been provided for ease of communication to re-confirm the restoration of the Company's Bonds on the Main Market of the London Stock Exchange.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings